PACS Group (NYSE:PACS) Director Mark Hancock Sells 155,682 Shares of Stock

PACS Group, Inc. (NYSE:PACS) Director Mark Hancock sold 155,682 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $42.47, for a total transaction of $6,611,814.54. Following the sale, the director owned 53,518,884 shares of the company’s stock, valued at $2,272,947,003.48. This trade represents a 0.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

• On Monday, September 14th, Mark Hancock sold 144,318 shares of PACS Group stock. The stock was sold at an average price of $44.57, for a total value of $6,432,253.26.
• On Thursday, July 9th, Mark Hancock sold 4,966 shares of PACS Group stock. The stock was sold at an average price of $45.06, for a total value of $223,767.96.
• On Wednesday, July 8th, Mark Hancock sold 20,338 shares of PACS Group stock. The stock was sold at an average price of $45.07, for a total value of $916,633.66.
• On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The shares were sold at an average price of $45.33, for a total value of $6,444,248.79.
• On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The shares were sold at an average price of $45.01, for a total value of $577,253.25.
• On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The stock was sold at an average price of $45.02, for a total value of $273,721.60.
• On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The stock was sold at an average price of $40.50, for a total value of $2,508,205.50.
• On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The stock was sold at an average price of $40.33, for a total value of $5,568,322.77.
• On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The shares were sold at an average price of $35.31, for a total value of $2,248,540.80.

PACS Group Trading Down 5.7%

Shares of PACS Group stock opened at $42.01 on Wednesday. PACS Group, Inc. has a 1 year low of $10.31 and a 1 year high of $49.49. The company’s fifty day simple moving average is $44.71 and its 200-day simple moving average is $39.13. The company has a market cap of $6.65 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 1.39 and a beta of -0.13. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, sell-side analysts expect that PACS Group, Inc. will post 2.13 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Truist Financial set a $62.00 price target on PACS Group in a report on Wednesday, September 2nd. UBS Group boosted their price objective on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Weiss Ratings lowered PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, August 5th. Oppenheimer raised their target price on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, JPMorgan Chase & Co. lifted their price target on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $58.80.

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Wall Street remains constructive on PACS Group. Truist Financial, Oppenheimer, UBS, and JPMorgan have assigned price targets ranging from $57 to $62, while the reported consensus target is $58.80 versus recent trading levels. Analysts cite the company’s growth outlook and maintain an overall “Moderate Buy” rating. PACS Group insider trading and analyst coverage
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected. This supports the case for continued earnings growth in PACS Group’s skilled-nursing and post-acute-care operations.
• Neutral Sentiment: PACS Group presented at the 2026 Jefferies Healthcare Services and Technology Conference on September 15. Management discussed operations and its growth strategy, but the announcement did not disclose new financial guidance or a material business update. PACS Group Jefferies conference announcement
• Negative Sentiment: Director Mark Hancock sold 300,000 shares across September 14–15 for roughly $13.0 million, while CEO Jason Murray sold more than 10,000 shares in the latest reported transactions. The sales add near-term supply and may concern investors, although Hancock and Murray still retain more than 53 million and 54 million shares, respectively; the reported sales represent only small reductions in their holdings. PACS Group director insider sale filing

Hedge Funds Weigh In On PACS Group

A number of hedge funds have recently modified their holdings of PACS. Financial Management Professionals Inc. lifted its holdings in PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after purchasing an additional 235 shares during the last quarter. Jacobsen Capital Management increased its holdings in shares of PACS Group by 1.6% during the first quarter. Jacobsen Capital Management now owns 18,128 shares of the company’s stock worth $582,000 after buying an additional 294 shares in the last quarter. Larson Financial Group LLC increased its holdings in shares of PACS Group by 127.0% during the fourth quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock worth $42,000 after buying an additional 612 shares in the last quarter. Strategic Advocates LLC raised its stake in shares of PACS Group by 18.5% in the fourth quarter. Strategic Advocates LLC now owns 5,182 shares of the company’s stock valued at $203,000 after acquiring an additional 808 shares during the last quarter. Finally, Peterson Wealth Services raised its stake in shares of PACS Group by 1.6% in the first quarter. Peterson Wealth Services now owns 53,672 shares of the company’s stock valued at $1,724,000 after acquiring an additional 854 shares during the last quarter.

PACS Group Company Profile

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.